AIM
ARK Investment Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Sell |
1,575,032
-15,878
| -1% | -$181K | 0.13% | 76 |
|
|
2025
Q1 | $18.9M | Buy |
1,590,910
+60,617
| +4% | +$720K | 0.19% | 68 |
|
|
2024
Q4 | $28.8M | Sell |
1,530,293
-686,072
| -31% | -$12.9M | 0.24% | 57 |
|
|
2024
Q3 | $49.8M | Sell |
2,216,365
-106,967
| -5% | -$2.4M | 0.46% | 43 |
|
|
2024
Q2 | $48.5M | Sell |
2,323,332
-312,006
| -12% | -$6.51M | 0.43% | 38 |
|
|
2024
Q1 | $38.7M | Sell |
2,635,338
-559,661
| -18% | -$8.23M | 0.27% | 56 |
|
|
2023
Q4 | $33M | Buy |
3,194,999
+601,952
| +23% | +$6.21M | 0.2% | 63 |
|
|
2023
Q3 | $20.4M | Buy |
2,593,047
+331,976
| +15% | +$2.61M | 0.16% | 76 |
|
|
2023
Q2 | $22.6M | Buy |
2,261,071
+21,212
| +0.9% | +$212K | 0.15% | 80 |
|
|
2023
Q1 | $19.9M | Buy |
2,239,859
+251,605
| +13% | +$2.23M | 0.14% | 73 |
|
|
2022
Q4 | $21.8M | Buy |
1,988,254
+701,732
| +55% | +$7.71M | 0.19% | 67 |
|
|
2022
Q3 | $16.8M | Buy |
1,286,522
+507,797
| +65% | +$6.62M | 0.12% | 90 |
|
|
2022
Q2 | $7.86M | Buy |
778,725
+386,734
| +99% | +$3.9M | 0.05% | 125 |
|
|
2022
Q1 | $5.49M | Buy |
391,991
+348,044
| +792% | +$4.88M | 0.02% | 152 |
|
|
2021
Q4 | $1.27M | Buy |
+43,947
| New | +$1.27M | ﹤0.01% | 250 |
|